Association of absolute lymphocyte count and peripheral blood lymphocyte subsets percentage with minimal residual disease at the end of induction in pediatric B cell acute lymphoblastic leukemia

References

• Anoceto Martínez A, González Otero A, Guerchicoff de Svarch E, et al. Contaje absoluto de linfocitos como factor pronóstico en la leucemia aguda linfoblástica del niño. An Pediatría. 2012;76(1):10.e1–10.e6. doi:10.1016/j.anpedi.2011.07.001.
   Google Scholar
• De Angulo G, Yuen C, Palla SL, Anderson PM, Zweidler-McKay PA. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: Implications for risk stratification and future studies. Cancer. 2008;112(2):407–415. doi:10.1002/cncr.23168.
   PubMed Web of Science ®Google Scholar
• Rabin KR, Gramatges MM, Borowitz MJ, et al. Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2012;59(3):468–474. doi:10.1002/pbc.23395.
   PubMed Web of Science ®Google Scholar
• Hirase S, Hasegawa D, Takahashi H, et al. Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia. Int J Hematol. 2015;102(5):594–601. doi:10.1007/s12185-015-1875-0.
   PubMed Web of Science ®Google Scholar
• Rubnitz JE, Campbell P, Zhou Y, et al. Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia: absolute lymphocyte counts in ALL. Cancer. 2013;119(11):2061–2066. doi:10.1002/cncr.28026.
   PubMed Web of Science ®Google Scholar
• Fungpipat P, Sophonphan J, Sosothikul D, Suppipat K. Redefining clinical risk classification in children with precursor B cell acute lymphoblastic leukemia using pre-treatment absolute lymphocyte count. Leuk Lymphoma. 2016;57(4):953–956. doi:10.3109/10428194.2015.1081194.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Luo Z, Yang S, et al. The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemia. Leuk Res. 2015;39(2):144–150. doi:10.1016/j.leukres.2014.11.013.
   PubMed Web of Science ®Google Scholar
• Gupta A, Kapoor G, Jain S, Bajpai R. Absolute lymphocyte count recovery independently predicts outcome in childhood acute lymphoblastic leukemia: Experience from a tertiary care cancer center of a developing country. J Pediatr Hematol Oncol. 2015;37(3):e143–e149. doi:10.1097/MPH.0000000000000249.
   PubMed Web of Science ®Google Scholar
• Farkas T, Müller J, Erdelyi DJ, Csoka M, Kovacs GT. Absolute lymphocyte count (ALC) after induction treatment predicts survival of pediatric patients with acute lymphoblastic leukemia. Pathol Oncol Res 2017;23(4):889–897.
   Web of Science ®Google Scholar
• Zeidler L, Zimmermann M, Moricke A, et al. Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcome. Haematologica. 2012;97(3):402–409. doi:10.3324/haematol.2011.045229.
   PubMed Web of Science ®Google Scholar
• Alkayed K. RE: “Lack of prognostic significance of absolute lymphocyte count after intensive induction therapy in childhood acute lymphoblastic leukemia” (PBC-12-0049.R2). Pediatr Blood Cancer. 2014;61(1):184. doi:10.1002/pbc.24749.
   PubMed Web of Science ®Google Scholar
• Bassan R, Intermesoli T, Scattolin A, et al. Minimal residual disease assessment and risk-based therapy in acute lymphoblastic leukemia. Clin Lymphoma Myeloma Leuk. 2017;17:S2–S9. doi:10.1016/j.clml.2017.02.019.
   Web of Science ®Google Scholar
• Berry DA, Zhou S, Higley H, et al. Association of minimal residual disease with clinical outcome in pediatric and adult acute lymphoblastic leukemia: a meta-analysis. JAMA Oncol. 2017;3(7):e170580. doi:10.1001/jamaoncol.2017.0580.
   PubMed Web of Science ®Google Scholar
• Shen H-Q, Feng J-H, Tang Y-M, et al. Absolute lymphocyte count is associated with minimal residual disease level in childhood B-cell precursor acute lymphoblastic leukemia. Leuk Res. 2013;37(6):671–674. doi:10.1016/j.leukres.2013.02.002.
   PubMed Web of Science ®Google Scholar
• Disis ML. Immune regulation of cancer. J Clin Oncol. 2010;28(29):4531–4538. doi:10.1200/JCO.2009.27.2146.
   PubMed Web of Science ®Google Scholar
• Lowdell MW, Craston R, Samuel D, et al. Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. Br J Haematol. 2002;117(4):821–827.
   PubMed Web of Science ®Google Scholar
• Moricke A, Reiter A, Zimmermann M, et al. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111(9):4477–4489. doi:10.1182/blood-2007-09-112920.
   PubMed Web of Science ®Google Scholar
• Chopra A, Pati H, Mahapatra M, et al. Flow cytometry in myelodysplastic syndrome: analysis of diagnostic utility using maturation pattern-based and quantitative approaches. Ann Hematol. 2012;91(9):1351–1362. doi:10.1007/s00277-012-1461-y.
   PubMed Web of Science ®Google Scholar
• Rolf N, Smolen KK, Kariminia A, et al. Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia. Cancer Immunol Immunother. 2018;67(2):225–236. doi:10.1007/s00262-017-2070-3.
   PubMed Web of Science ®Google Scholar
• Low M, Lee D, McLean C, Nguyen T, Morgan S, Grigoriadis G. Detectable CD8 cells correlate with improved overall survival in adult B lymphoblastic leukaemia patients. Br J Haematol. 2014;165(6):883–885. doi:10.1111/bjh.12794.
   PubMed Web of Science ®Google Scholar
• Lustfeld I, Altvater B, Ahlmann M, et al. High proportions of CD4+ T cells among residual bone marrow T cells in childhood acute lymphoblastic leukemia are associated with favorable early responses. Acta Haematol. 2014;131(1):28–36. doi:10.1159/000351429.
   PubMed Web of Science ®Google Scholar
• Rutkauskaitė V, Ragelienė L, Matuzevičienė R, Sinkevič K, Mauricas M, Characiejus D. Reduction in proportion of senescent CD8+ T lymphocytes during chemotherapy of children with acute lymphoblastic leukemia. Anticancer Res. 2016;36(11):6195–6199. doi:10.21873/anticanres.11213.
   PubMed Web of Science ®Google Scholar
• Pui CH, Ip SH, Dodge RK, et al. Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients. Blood. 1988;72(3):1015–1021.
   PubMed Web of Science ®Google Scholar
• Shand JC, Kanu A, Fry TJ. CD8 suppressor cells can be induced by Pre-B acute lymphoblastic leukemia as a potential mechanism of immune escape. Blood. 2012;120(21):4797–4797.
   Web of Science ®Google Scholar